サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784913

美容注射の世界市場

Aesthetic Injectables

出版日
ページ情報
英文 212 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
美容注射の世界市場
出版日: 2025年08月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 212 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

美容注射の世界市場は2030年までに273億米ドルに達する見込み

2024年に157億米ドルと推定される美容注射の世界市場は、2030年には273億米ドルに達し、分析期間2024-2030年のCAGRは9.6%で成長すると予測されます。ボツリヌス毒素美容注射は、本レポートで分析したセグメントの一つであり、CAGR 11.1%を記録し、分析期間終了時には180億米ドルに達すると予測されています。ダーマフィラー美容注射セグメントの成長率は、分析期間中CAGR 7.1％と推定されます。

米国市場は41億米ドルと推定、中国はCAGR 9.2％で成長予測

米国の美容注射市場は、2024年に41億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに43億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.0％と8.0％と予測されています。欧州では、ドイツがCAGR 7.6%で成長すると予測されています。

世界の美容注射市場- 主要動向と促進要因のまとめ

美容・健康産業で美容注射需要が急増している理由とは？

ソーシャルメディアの影響や美の基準の進化により、個人の外見やセルフケアが重視されるようになったことが、美容注射の需要を大きく押し上げています。顔の美観を向上させ、老化の兆候を遅らせるために、低侵襲の美容整形を求める人が増えており、美容注射は若い層から年配の層まで幅広く受け入れられています。ボトックス、皮膚充填剤、その他の注入剤は、もはやセレブや高所得者層に限定されるものではなく、その手頃な価格と利用しやすさにより、より幅広い消費者層にその範囲が広がっています。さらに、消費者が若々しい肌を維持するために早期介入治療を選択する予防美容に対する意識の高まりが、市場成長の原動力となっています。可処分所得の増加や非外科的代替医療へのシフトと相まって、美容強化の受け入れが増加していることが、様々な地域における美容注射の需要をさらに促進しています。

技術の進歩と製品の革新は市場をどのように変えているか？

製剤技術や注入技術の進歩は美容注射市場に革命をもたらし、施術をより安全で効果的、そして長持ちさせる。ヒアルロン酸ベースのフィラー、長寿命化したボツリヌス毒素、コラーゲン産生を促進するバイオスティミュレーターを特徴とする新世代の注入剤は、消費者にも施術者にも支持されています。これらの技術革新は、より自然な仕上がりをもたらし、過剰治療に対する懸念を軽減し、患者の満足度を高めています。さらに、マイクロカニューレや針を使わない注射システムの登場により、精度が向上し、不快感が最小化されたため、こうした施術を選ぶ人がさらに増えています。美容カウンセリングにおける人工知能（AI）と3D画像技術の統合もまた、患者の体験を一変させ、施術者がより高い精度で治療計画をカスタマイズすることを可能にしています。持続時間の延長、質感の向上、副作用の軽減に焦点を当てた継続的な製品開発により、市場は多様な消費者の嗜好に応える革新的なソリューションの着実な流入を目の当たりにしています。

美容注射市場の課題と機会とは？

堅調な成長にもかかわらず、美容注射市場は、規制の精査、熟練した施術者の必要性、偽造品や低品質製品に関連する安全性の懸念といった課題に直面しています。製品の承認や管理基準に関して保健当局が課す厳しい規制は、新規参入の障壁となり、特定の市場での特定の注射剤の入手を制限します。さらに、注入者の適切な訓練や専門知識の不足は、左右非対称、あざ、副作用などの合併症を引き起こす可能性があり、施術に対する消費者の信頼に影響を与える可能性があります。しかし、このような課題は、安全で効果的な使用を保証するために、専門家養成プログラム、製品認証、消費者啓蒙活動に投資する機会を市場プレーヤーに提供しています。エステティック・クリニックやメディカル・スパの増加に牽引されて拡大する医療美容業界は、メーカーがプレミアムで的を絞ったソリューションを導入する有利な機会を提供しています。美容施術が急速に普及しているアジア太平洋とラテンアメリカの新興市場もまた、業界参入企業にとって未開拓の成長の可能性を秘めています。

美容注射市場の成長を促進する主な要因は？

美容注射市場の成長は、非外科的美容強化に対する需要の高まり、予防的美容治療の採用の増加、ソーシャルメディアや有名人の推薦の影響力の拡大など、いくつかの要因によって牽引されています。ダウンタイムが少なく、手ごろな価格で、侵襲性の低い施術を素早く受けたいという志向の高まりが、さまざまな層で注入剤に対する需要の急増につながっています。加えて、アンチエイジングの解決策を求める高齢化社会と、輪郭形成や強化治療を選ぶ若い世代が、一貫した市場成長の原動力となっています。eコマース・プラットフォームやデジタル診察の拡大により、美容治療へのアクセスがさらに簡素化され、消費者が利用可能な選択肢を検討しやすくなっています。美容企業と皮膚科クリニックの共同研究開発への注目の高まりは、技術革新を促進し、市場で入手可能な注入可能製品の範囲を拡大しています。美容治療が社会のタブーを破り、主流に受け入れられるようになるにつれ、美容注射市場は今後数年間で持続的な成長が見込まれます。

セグメント

タイプ（ボツリヌストキシン美容注射、ダーマフィラー美容注射）;性別（女性、男性）;年齢層（15～30歳、31～40歳、41～50歳、51～60歳、60歳以上）;エンドユーザー（病院、皮膚科クリニック、その他）

調査対象企業の例

  • BIOXIS Pharmaceuticals, SAS
  • Croma-Pharma GmbH
  • Galderma S.A.
  • Laboratoires Vivacy SAS
  • Medytox, Inc.
  • Merz Pharma GmbH & Co. KGaA.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma PLC
  • Teoxane SA
  • Mesoestetic E-commerce S.L.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29019

Global Aesthetic Injectables Market to Reach US$27.3 Billion by 2030

The global market for Aesthetic Injectables estimated at US$15.7 Billion in the year 2024, is expected to reach US$27.3 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Botulinum Toxin Aesthetic Injectables, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$18.0 Billion by the end of the analysis period. Growth in the Dermal Fillers Aesthetic Injectables segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 9.2% CAGR

The Aesthetic Injectables market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Aesthetic Injectables Market - Key Trends & Drivers Summarized

Why Is Demand for Aesthetic Injectables Surging Across the Beauty and Wellness Industry?

The growing emphasis on personal appearance and self-care, driven by social media influence and evolving beauty standards, has significantly propelled the demand for aesthetic injectables. With an increasing number of individuals seeking minimally invasive cosmetic procedures to enhance their facial aesthetics and delay signs of aging, aesthetic injectables have gained widespread acceptance among both younger and older demographics. Botox, dermal fillers, and other injectables are no longer limited to celebrities and high-income groups; their affordability and accessibility have expanded their reach across a broader consumer base. Additionally, the rising awareness of preventive aesthetics, where consumers opt for early intervention treatments to maintain youthful skin, is driving market growth. The increasing acceptance of cosmetic enhancements, coupled with growing disposable incomes and a shift towards non-surgical alternatives, is further fueling demand for aesthetic injectables in various regions.

How Are Technological Advancements and Product Innovations Transforming the Market?

Advancements in formulation technologies and injection techniques are revolutionizing the aesthetic injectables market, making procedures safer, more effective, and longer-lasting. New-generation injectables featuring hyaluronic acid-based fillers, botulinum toxins with improved longevity, and bio-stimulators that promote collagen production are gaining traction among consumers and practitioners alike. These innovations provide more natural-looking results, reducing concerns about over-treatment and enhancing patient satisfaction. Additionally, the advent of micro-cannulas and needle-free injection systems has improved precision and minimized discomfort, further encouraging individuals to opt for these procedures. The integration of artificial intelligence (AI) and 3D imaging technology in aesthetic consultations is also transforming the patient experience, enabling practitioners to customize treatment plans with higher accuracy. With continuous product development focusing on extended duration, improved texture, and reduced side effects, the market is witnessing a steady influx of innovative solutions catering to diverse consumer preferences.

What Are the Challenges and Opportunities in the Aesthetic Injectables Market?

Despite the robust growth, the aesthetic injectables market faces challenges such as regulatory scrutiny, the need for skilled practitioners, and safety concerns associated with counterfeit or low-quality products. Stringent regulations imposed by health authorities regarding product approval and administration standards create barriers for new entrants and limit the availability of certain injectables in specific markets. Moreover, the lack of proper training and expertise among injectors can result in complications such as asymmetry, bruising, or adverse reactions, which may impact consumer trust in the procedure. However, these challenges present opportunities for market players to invest in professional training programs, product certifications, and consumer awareness initiatives to ensure safe and effective use. The expanding medical aesthetics industry, driven by the increasing number of aesthetic clinics and medical spas, offers lucrative opportunities for manufacturers to introduce premium and targeted solutions. Emerging markets in Asia-Pacific and Latin America, where aesthetic procedures are rapidly gaining popularity, also present untapped growth potential for industry participants.

What Are the Key Factors Driving Growth in the Aesthetic Injectables Market?

The growth in the Aesthetic Injectables market is driven by several factors, including the rising demand for non-surgical cosmetic enhancements, increasing adoption of preventive aesthetic treatments, and the expanding influence of social media and celebrity endorsements. The growing inclination towards quick, affordable, and minimally invasive procedures with minimal downtime has led to a surge in demand for injectables across various demographics. Additionally, the aging population seeking anti-aging solutions and the younger generation opting for contouring and enhancement treatments are driving consistent market growth. The expansion of e-commerce platforms and digital consultations has further simplified access to aesthetic treatments, making it easier for consumers to explore available options. The increasing focus on research and development, along with collaborations between aesthetic companies and dermatology clinics, is fostering innovation and expanding the range of injectable products available in the market. As aesthetic treatments continue to break societal taboos and gain mainstream acceptance, the market for aesthetic injectables is expected to witness sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Aesthetic Injectables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Botulinum Toxin Aesthetic Injectables, Dermal Fillers Aesthetic Injectables); Gender (Female Gender, Male Gender); Age Group (15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group, Above 60 Age Group); End-Use (Hospitals End-Use, Dermatology Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • BIOXIS Pharmaceuticals, SAS
  • Croma-Pharma GmbH
  • Galderma S.A.
  • Laboratoires Vivacy SAS
  • Medytox, Inc.
  • Merz Pharma GmbH & Co. KGaA.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma PLC
  • Teoxane SA
  • Mesoestetic E-commerce S.L.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Aesthetic Injectables - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-Surgical Cosmetic Procedures Spurs Growth in Aesthetic Injectables Market
    • Growing Popularity of Preventative Aesthetic Treatments Expands Addressable Market for Injectables
    • Advancements in Hyaluronic Acid and Biostimulatory Fillers Enhance Longevity and Efficacy of Treatments
    • Increasing Male Aesthetic Awareness and Treatment Acceptance Drives Growth in the Injectables Segment
    • Surging Influence of Social Media and Celebrity Endorsements Strengthens Demand for Facial Fillers and Neurotoxins
    • Innovations in Painless and Micro-Dosing Injection Techniques Propel Adoption Among First-Time Users
    • Rising Disposable Income and Increased Consumer Spending on Beauty and Wellness Fuel Market Expansion
    • Development of Long-Lasting and Reversible Aesthetic Injectables Creates New Market Opportunities
    • Expanding Applications of Injectables in Medical and Therapeutic Treatments Strengthen Market Position
    • Growing Trend of Combination Therapies with Injectables and Energy-Based Devices Drives Market Growth
    • Regulatory Approvals for New and Next-Generation Neurotoxins Spur Competitive Market Dynamics
    • Increasing Focus on Personalized Aesthetic Treatments Enhances Demand for Tailored Injectable Solutions
    • Expansion of Medical Spas and Non-Surgical Aesthetic Clinics Drives Accessibility and Adoption of Injectables
    • Rising Concerns Over Counterfeit and Unregulated Injectables Create Regulatory and Market Challenges
    • Growing Awareness of Collagen-Boosting Injectables Accelerates Demand for Bio-Regenerative Fillers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aesthetic Injectables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Botulinum Toxin Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Botulinum Toxin Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Dermal Fillers Aesthetic Injectables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Dermal Fillers Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Dermatology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Dermatology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for 15 - 30 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for 15 - 30 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 31 - 40 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for 31 - 40 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for 41 - 50 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for 41 - 50 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for 51 - 60 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for 51 - 60 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Above 60 Age Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Above 60 Age Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • JAPAN
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • CHINA
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • EUROPE
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Aesthetic Injectables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • FRANCE
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • GERMANY
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • UNITED KINGDOM
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Aesthetic Injectables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Type - Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Aesthetic Injectables by Type - Percentage Breakdown of Value Sales for Botulinum Toxin Aesthetic Injectables and Dermal Fillers Aesthetic Injectables for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by End-Use - Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Aesthetic Injectables by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Dermatology Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Aesthetic Injectables by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Aesthetic Injectables by Age Group - 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Aesthetic Injectables by Age Group - Percentage Breakdown of Value Sales for 15 - 30 Age Group, 31 - 40 Age Group, 41 - 50 Age Group, 51 - 60 Age Group and Above 60 Age Group for the Years 2025 & 2030

IV. COMPETITION